Cell and Tissue Preservation Market - Global Market Share, Trends, Analysis and Forecast 2023 – 2032

The global cell and tissue preservation market size was estimated to be US$ 4.3 billion in 2022 and is expected to reach US$ 12.4 Billion by 2032 at a CAGR of 11.3%.

The current techniques for cell and tissue preservation include freeze-drying, deep-freezing, and cryopreservation. Deep-freezing is an normal preservation technique for tendon and meniscal allografts, involving essentially freezing the tissue to up to −80 °C. This procedure helps in saving a few cells and gives a 10-year timeframe of usability further.

Cryopreservation is the method of freezing tissues and cells at low temperatures to keep the organic material metabolically dormant, to keep up with its practicality, and to forestall ice crystal formation. These can upset the lining of the cell or tissue, resulting in death of the cell. Cells are cryopreserved to limit hereditary change and prohibit misfortune through defiling of cells.

Cryopreservation is utilized for the preservation of microorganisms, tissue cells, set up cell lines, little multicellular organisms, and complex cellular constructions like embryos, organisms, nucleic acid, and proteins. Different sorts of medium or serum are utilized to freeze cells. Glycerol and dimethyl sulfoxide (DMSO) are the most generally utilized other options. Glycerol and dimethyl sulfoxide are blended into a liquid with serum or medium, wherein cells are set and frozen in fluid nitrogen cooler.

Biopreservation is one of the significant sectors where significant vital participants are initiating financial investments, subsequently helping the development of the cell and tissue preservation market. End-clients of the market like emergency clinics, gene banks, and biobanks are empowering the business players to propel in the exploration and improvements of cutting-edge techniques to help patient results.

Another factor that upholds the development of the worldwide market is the public authority encouragement towards innovation in form of funds and awards to empower Research and development exercises by different colleges and associations. Likewise, benefits of cell freezing for capacity in drug advancement or in different projects are probably going to fuel the development of the market during 2021-2031.

Dispatch of cutting-edge and novel cryopreservation models and the endorsement of cryopreserved cells by administrative specialists is additionally projected to cultivate market development significantly.

Developing medical services consumption is a huge contributing element to this market. This upsurge in medical services spending is a result of quick monetary improvement across the globe. Step-up in medical services consumption further is anticipated to further develop admittance to quality medical care and latest techniques, which incorporate biopreservation agencies, along these lines expanding development possibilities. As far as end-client, biobanks show a promising development rate during the forecast period. Distinctive biospecimens are put away in the biobanks. These samples incorporate cells and tissues, organs or appendages, and so on. Accordingly, these factors help the development of the biobanks segment in the cell and tissue preservation market.

Manufacturers are seen fixated on creating novel items for saving different cells, proactive government drives for endorsement of research exercises in the drug and biopharmaceutical ventures, and decline in fertility rate are a few factors that drive the development of the cryopreservation of cell market since past few years.

Expanding commitment of the drug organizations in the capitalization of the preservation hardware and its reception has energized the development of the market. Developing patient populace and the exponential rise in the requirement for therapy of persistent sicknesses has altogether acquired the demand for cell & tissue preservation arrangements and services. Tissues type segment is postulated to hold the significant share in the cell and tissue preservation market. The expected CAGR for the segment is sizable during the forecast period of 2021 to 2031.

North America expects being the predominant district in the cell and tissue preservation market during the above cited projection period. Other evident areas contributing significantly to the development of the cell and tissue preservation market are Asia Pacific and Europe.

Cell and Tissue Preservation Market Value Share Analysis, by Geography (2022)

The report titled “Cell and Tissue Preservation Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032”, wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Cell and Tissue Preservation Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

The Cell and Tissue Preservation market is segmented as product, application, cell provider, and region. Based on product type, the Cell and Tissue Preservation market is segmented into Equipment (Freezers, Refrigerators), Consumables (Vials, Straws, Microtite Plates, Bags), Liquid Nitrogen, Media, Pre-formulated, Home-brew, Laboratory Information Management System (LIMS), other. Based on application, the Cell and Tissue Preservation market is segmented into Regenerative Medicine (Cell therapy, Gene therapy, others), Bio-banking (Human eggs, Human sperms, Veterinary IVF), Drug Discovery, Others. Based on cell provider, the Cell and Tissue Preservation market is segmented into CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, others.

Based on geography, the Cell and Tissue Preservation Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Cell and Tissue Preservation Market. Further, market share of prominent companies in the Cell and Tissue Preservation Market would also be estimated. 

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Cell and Tissue Preservation companies. The Cell and Tissue Preservation Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Cell and Tissue Preservation business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Cell and Tissue Preservation Market.

The key players of the Cell and Tissue Preservation Market are CellGenix GmbH, BD, Merck KGaA, Lonza, Cytiva, Avantor, Inc., FUJIFILM Irvine Scientific, Agilent Technologies, Inc., AMSBIO, Princeton CryoTech, BioLifeSolutions Inc., STEMCELL Technologies Inc., Corning Incorporated, LGC SeraCare, and others.

Cell and Tissue Preservation Market Key Segments:

Based on product

• Equipment
  • Freezers
  • Refrigerators
  • Consumables
    • Vials
    • Straws
    • Microtiter Plates
    • Bags
  • Liquid Nitrogen
  • Media
  • Pre-formulated
    • Home-brew
    • Laboratory Information Management System (LIMS)
  • others

Based on application

• Regenerative Medicine
  • Cell therapy
  • Gene therapy
  • Others
• Bio-banking
  • Human eggs
  • Human sperms
  • Veterinary IVF
• Drug Discovery
• Others

Based on cell provider

• CD34+
• CD19+
• MSC
• iPSC
• hESC
• Tumor Cells
• Others

By Region

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  
  • Japan
  • India
  • China
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East & Africa
  •  UAE
  • Saudi Arabia
  • South Africa
  • Rest of the Middle East & Africa
• South America
  • Brazil
  • Rest of South America